Capital Senior Living Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Kimberly Lody
- Full Time Employees
- 3,200
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 14160 Dallas Pkwy Ste 300 Dallas TX United States of America 75254
- IPO Date
- Oct 31, 1997
- CIK
- 0001043000
- Website
- capitalsenior.com
- Similar Companies
- Business
- Capital Senior Living Corporation Capital Senior Living Corporation (ticker: CSU), operating as Sonida Senior Living, owns, operates, leases, and manages senior housing communities across the United States, providing a continuum of care services including independent living with daily meals, housekeeping, laundry, transportation, social and recreational activities, exercise classes, and 24-hour staffing; assisted living featuring personal care support for activities of daily living such as ambulation, bathing, dressing, grooming, medication management, and around-the-clock nursing assistance; memory care through its signature Magnolia Trails program offering specialized, person-centered environments for residents with Alzheimer's and dementia, incorporating tailored daily care, engaging activities, nutrition, and meaningful connections; and respite care for short-term stays with access to community amenities. The company serves seniors primarily aged 75 and older, enabling them to age in place across its portfolio of approximately 75 communities in 18 states with capacity for nearly 7,000 residents, including both owned/leased properties and third-party managed facilities; it emphasizes resident-centric programming such as educational classes, spiritual services, fitness options, restaurant-style dining, and hobby clubs to foster independence, wellness, and social engagement. Founded in 1990 and headquartered in Dallas, Texas, Capital Senior Living rebranded to Sonida Senior Living in November 2021 following a $154.8 million investment from Conversant Capital to support portfolio growth, operational improvements, and strategic expansion into third-party management and continuum-of-care properties; recent developments include strengthened revenue growth with a 26.3% increase in resident revenue for Q3 2025 compared to the prior year, ongoing debt restructuring efforts, and pursuit of mergers such as a proposed $1.8 billion stock-and-cash transaction with CNL Healthcare Properties to create one of the largest U.S. senior housing operators.
CORA Group Acquires Finastra's Phoenix Core System, Malauzai Digital Banking and Fusion Analytics Businesses
Constellation Software Inc. Confirms Closing of DerbySoft Acquisition Through Juniper Group
Constellation Software Inc. (CSU:CA) Shareholder/Analyst Call Transcript
Constellation Software Inc. Announces Results of Voting for Directors at Annual General Shareholders' Meeting
Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2026 and Declares Quarterly Dividend
Celldex: A Mast Cell Reset Story Hiding Inside A CSU Trial
Constellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2026
Dupixent® (dupilumab) Approved in the U.S. as the First Biologic Medicine for Young Children with Uncontrolled Chronic Spontaneous Urticaria (CSU)
Constellation Software Inc. Announces Conference Call to Discuss First Quarter Results
Constellation Software's Vela Operating Group Enters into Agreement to acquire a majority interest in Derbysoft Holdings Limited
Dupixent® (dupilumab) Approved in the EU as the First Targeted Medicine to Treat Young Children with Chronic Spontaneous Urticaria (CSU)
Constellation Software Inc. (TSE:CSU) Given Average Rating of “Moderate Buy” by Analysts
Constellation Software Inc. Announces Mark Leonard's Decision to not Stand for Re-Election to Board of Directors
Constellation Software Inc. (CSU:CA) Q4 2025 Earnings Call Transcript
Celldex Presents Additional Positive Data from Phase 2 Chronic Spontaneous Urticaria (CSU) and Phase 2 Cold Urticaria (ColdU) and Symptomatic Dermographism (SD) Studies Further Demonstrating First-in-Class and Best-in-Disease Barzolvolimab Profile at AAAAI 2026
Dupixent® (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
Novartis presents Rhapsido® (remibrutinib) data at AAAAI, showing potential beyond chronic spontaneous urticaria (CSU)
Constellation Software Inc. Announces Conference Call to Discuss Fourth Quarter Results
Constellation Software (TSE:CSU) Reaches New 52-Week Low – Time to Sell?